Istituto Ortopedico Rizzoli

At Istituto Ortopedico Rizzoli in Bologna, clinical trials in musculoskeletal diseases focus on conditions that affect bones, joints, and connective tissues, with a strong emphasis on osteogenesis imperfecta, osteosarcoma, and challenging fracture healing.

• Testing new treatments for brittle bone disease and reducing fracture risk in osteogenesis imperfecta
• Evaluating therapies for delayed union and non-union long bone fractures to improve bone repair
• Studying treatment approaches for osteosarcoma and other high-risk bone sarcomas

This research area aims to improve healing, strengthen bone outcomes, and support better long-term function for patients with complex orthopedic conditions.

A major part of the site’s work is dedicated to neoplasms, especially rare and aggressive cancers such as leiomyosarcoma, chondrosarcoma, Ewing sarcoma, and soft tissue sarcoma.

• Assessing new anticancer therapies for advanced or metastatic sarcomas
• Comparing treatment strategies to improve survival and disease control in leiomyosarcoma
• Studying options for refractory or recurrent Ewing sarcoma and other difficult-to-treat sarcomas

The goal is to find more effective and better-tolerated treatments for patients with rare cancers that often have limited standard options.

The Research, Innovation and Technology Department also supports trials exploring targeted and immune-based approaches for advanced cancers, including tenosynovial giant cell tumor, desmoid tumors, and selected sarcoma subtypes.

• Testing targeted therapies designed to slow or stop tumor growth
• Evaluating immune-focused treatments for advanced solid tumors
• Measuring whether new combinations can improve tumor response and progression control

These studies are aimed at expanding treatment choices and improving outcomes for patients with hard-to-treat tumors.

The site also conducts research in immune system diseases, with attention to non-radiographic axial spondyloarthritis and related inflammatory conditions that can cause pain, stiffness, and reduced mobility.

• Evaluating medicines that help maintain remission and prevent disease flare-ups
• Studying how well treatments control inflammation over time
• Supporting better symptom management and quality of life in chronic immune-mediated disease

This work seeks to improve long-term disease control while reducing the burden of persistent inflammation for patients.

Research at Istituto Ortopedico Rizzoli also extends to skin and connective tissue diseases and advanced orthopedic innovation, reflecting the center’s interest in tissue repair, structural recovery, and supportive care.

• Exploring therapies that may improve connective tissue healing and recovery
• Assessing treatment effectiveness in complex orthopedic and tumor-related conditions
• Investigating ways to improve diagnostics, response assessment, and patient outcomes

This broad research activity connects laboratory insight with clinical care, helping advance treatment for patients with rare and difficult musculoskeletal disorders.